Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 4.610
+0.010 (0.22%)
Jul 22, 2026, 9:23 AM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €128.8 million as of July 21, 2026. Its market cap has decreased by -31.55% in one year.
Market Cap
128.80M
Enterprise Value
116.64M
Revenue
7.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.61
ChartMarket Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 128.80M, a decrease of -47.36%. That is a compound annual growth rate of -10.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 128.80M | -32.75% |
| Dec 31, 2025 | 191.52M | 4.59% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.15B |
| UCB SA | 45.55B |
| Financière de Tubize | 9.17B |
| Onward Medical | 170.69M |
| European Medical Solutions | 17.52M |
| Celyad Oncology | 10.70M |
| BioSenic | 1.31M |
| Oxurion NV | 248.34K |